Produktbild: Advances in Brain Tumor Therapy
Vorbesteller Neu

Advances in Brain Tumor Therapy From Molecular Mechanisms to Clinical Practice

184,99 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

01.08.2026

Herausgeber

Arun Kumar Singh + weitere

Verlag

Elsevier

Seitenzahl

350

Maße (L/B)

23,5/19,1 cm

Gewicht

449 g

Sprache

Englisch

ISBN

978-0-443-44117-2

Beschreibung

Portrait

Dr. Arun Kumar Singh is an assistant professor in the Department of Pharmacy at Vivekanand Global University, Jaipur. He completed both his MPharm in Pharmaceutics and his PhD at Galgotias University, Greater Noida. His research strengths lie in AI-driven cancer research, nano-formulation, and the intersection of blockchain, IoT, machine learning, big data, and neuroscience with pharmaceutical science. He has authored books and contributed chapters on big data and cancer, and his work includes reviews published in reputable journals. His research appears across publishers such as IOP, Elsevier, CRC Press, and Wiley, reflecting a broad publication record and ongoing contributions to AI-enabled oncology and advanced drug delivery.

Prof. (Dr.) Rajwinder Kaur is the Assistant Dean of Pharm D (Academics) at Chitkara College of Pharmacy, Chitkara University, Punjab, India. With sixteen years of experience in teaching and research, she has held positions such as DST Women Scientist (WOS-A) at Punjab University, Chandigarh, and received prestigious fellowships like the CSIR-SRF and UGC-MRP. Dr. Kaur was awarded the "Dr. Harpal Singh Buttar and Harinder Kaur Buttar Young Scientist Award in Pharmaceutical Sciences for Rural Women" in 2013 and the Young Scientist Award "Women in Pharmaceutical Sciences" in 2023. Her research focuses on computational drug design, synthesis of fused-heterocyclic compounds, nanomedicine, and AI, particularly in inflammation, asthma, and neurological disorders. Dr. Kaur has published over 50 papers and 10 book chapters, and has edited a book. She is a senior member of the Hong Kong Chemical, Biological & Environmental Engineering Society (HKCBEES) and a life member of the Indian Pharmacy Graduate Association (IPGA).

Dr. Thakur Gurjeet singh possesses comprehensive knowledge of basic principles of clinical and preclinical drug development, derived from extensive graduate training in Pharmacology. Conducted research focused on the neuroprotective mechanism of Pharmacological preconditioning, Alzheimer, Parkinsonism. As Pharmacological preconditioning plays an important role in neurodegenerative disorders so extensive information, regarding protective role of adenosine, Opioid, CGRP, calcium, protein kinase-C, heat shock proteins and MAP kinase as triggering mechanism in Pharmacological preconditioning, is provided. Research is oriented to find out the noval pathways of Pharmacological preconditioning in neurodegenerative disorders and drug dependence such as brain stroke by using various drugs like Morphine, Capsaicin. Mechanistic studies related with drug dependence like Nicotine, Alcohol and Morphine dependence. Key research expertise areas include: Animal models development and validation. Neurodegenerative disorders (Stroke, Epilepsy, Dementia, Alzheimer & Parkinson), substance dependence Nicotine dependence, Morphine dependence, Alcohol dependence, ALS, Stem cell Therapy, Tardive Dyskinesia, Parkinson, Preconditioning and anesthetic techniques, histopathological and various behavioral data evaluation.

Dr. Ashutosh Pareek, Associate Professor at Banasthali Vidyapith with over 15 years of experience in pharmaceutical sciences, holds gold medals for his Master's and Bachelor's degrees in Pharmacy. Dr. Pareek specializes in neuropharmacology and innovative drug delivery systems, focusing on neurodegenerative disorders, cancer, and autoimmune diseases. His research includes developing advanced drug delivery systems for immunomodulators like naringenin. Dr. Pareek leads a research team working on these critical health issues and has published over 45 research papers and authored five technical books. He holds an international formulation patent and has received numerous awards, including the Zee National Achievers Award 2023. His work is funded by national and international agencies such as ICMR, DST-SERB, DBT, the American Association of Pharmaceutical Scientists, and the International Brain Research Organization. He serves as a Review Editor for Frontiers in Pharmacology and Frontiers in Oncology and reviews for leading journals by Elsevier, Springer, and Bentham.

Dr. Niraj Kumar Jha is an assistant professor in the Department of Biotechnology at Sharda University, Greater Noida, India, and a member of the Royal Society of Biology, London. Previously, he served as an assistant professor at the Noida Institute of Engineering and Technology, affiliated with Abdul Kalam Technical University. He holds an MSc in Biotechnology from Vellore Institute of Technology and a Ph.D. in Biotechnology from Delhi Technological University, supported by a research fellowship from the Department of Biotechnology, Government of India. A prolific author, Dr. Jha has published over 150 scholarly works and presented his research at international conferences. He currently serves as an associate editor for IET Nanobiotechnology and guest editor for several high-impact journals. His research interests focus on the pathogenesis of neurodegenerative, cancer, respiratory, and cardiovascular diseases, as well as the therapeutic roles of small molecules from natural or synthetic sources.

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

01.08.2026

Herausgeber

Verlag

Elsevier

Seitenzahl

350

Maße (L/B)

23,5/19,1 cm

Gewicht

449 g

Sprache

Englisch

ISBN

978-0-443-44117-2

Herstelleradresse

Libri GmbH
Europaallee 1
36244 Bad Hersfeld
DE

Email: gpsr@libri.de

Kundinnen und Kunden meinen

0 Bewertungen

Informationen zu Bewertungen

Zur Abgabe einer Bewertung ist eine Anmeldung im Konto notwendig. Die Authentizität der Bewertungen wird von uns nicht überprüft. Wir behalten uns vor, Bewertungstexte, die unseren Richtlinien widersprechen, entsprechend zu kürzen oder zu löschen.

Die Bewertungen sind nach Format, Anzahl Sterne und Datum sortiert.

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kund*innen durch Ihre Meinung

Kundinnen und Kunden meinen

0 Bewertungen filtern

  • Produktbild: Advances in Brain Tumor Therapy
  • 1. Introduction to Brain Tumors
    2. Molecular Pathogenesis of Brain Tumors
    3. Pharmacokinetics and Pharmacodynamics in Brain Tumor Treatment
    4. Conventional Chemotherapeutic Approaches for Brain Tumor Treatment
    5. Targeted Molecular Therapies for Brain Tumor
    6. Immunotherapy and Brain Tumors
    7. Epigenetic Therapies for Brain Tumor
    8. Nanotechnology and Drug Delivery Systems for Brain Tumor
    9. Stem Cells in Brain Tumor Therapy
    10. Harnessing Oxidative Stress: Novel Therapeutics in Pediatric Brain Cancer
    11. Advanced Imaging Techniques in Brain Tumor Diagnosis and Surgery
    12. Combination Therapies for Brain Therapy: Synergistic Approaches
    13. Decoding MGMT: Biochemistry, Drug Resistance, and Diagnostic Innovations
    14. Molecular Mechanisms of Drug Resistance in Brain Therapy
    15. Personalized Medicine in Brain Tumors
    16. Innovations and Obstacles in Pediatric Brain Cancer Therapy
    17. Clinical Trials and Regulatory Aspects for Brain Tumor Treatment
    18. Future Directions in Brain Tumor Therapy
    19. Case Studies and Real-World Applications